Taking people in TürkiyeNo phase
Effect of Expiratory Muscle Strength in Patients With Bronchiectasis
Key facts
- Who runs it
- Nisanur Tutuş
- Where
- Istanbul, TürkiyeSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 64 people, planned
- Started
- Aug 2025
- Planned end
- Jun 2026
- Type of study
- Observational
- Record updated
- 24 August 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Having a diagnosis of non-cystic fibrosis bronchiectasis
- Without an acute infection at the time of assessment (confirmed by medical history, serum C-reactive protein levels, chest X-ray and/or HRCT)
- Being between 18 and 65 years of age
Who cannot take part
- Stroke (Cerebrovascular accident - CVA)
- Unstable cardiac disease
- Myopathies
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in Türkiye
- Süreyyapaşa Chest Diseases and Chest Surgery Training and Research HospitalIstanbul, TürkiyeContact: Nisanur TutuşTaking people
About the trial
What the trial wants to find out
This study investigates the relationship between expiratory muscle strength and clinical outcomes such as disease severity, hospital admissions, and quality of life in individuals with bronchiectasis.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Expiratory Muscle Strength on Hospital Admission, Disease Severity and Quality of Life in Patients With Bronchiectasis
- Fit questions
- Built from NCT07104942, who can take part
- Record updated
- 24 August 2025